BRCA and HNPCC Carriers in PLCO |
Paul Pinsky |
NCI |
PLCO |
Jul 17, 2020 |
PLCO-644 |
Impact of Prostatitis and Benign Prostate Hyperplasia (BPH) on risk factors for Prostate Cancer |
Andrew Marks |
Claremont Graduate University |
PLCO |
Jul 17, 2020 |
PLCO-641 |
Prediction of an individual's smoking habits using saliva microbial signatures |
Manfred Kayser |
Erasmus MC Medical Center University Rotterdam |
PLCO |
Jul 17, 2020 |
PLCO-647 |
Blood groups and inflammatory marker levels |
Charles Rabkin |
DCEG |
PLCO |
Jul 17, 2020 |
PLCO-646 |
Genderd differences in stage and radiotherapy |
Cristina Sarasqueta |
Instituto Biodonostia |
PLCO |
Jun 26, 2020 |
PLCO-640 |
Evaluating six-step parsimonious quadratic logistic regression for risk prediction |
Stuart Baker |
National Cancer Institute |
PLCO |
Jun 18, 2020 |
PLCO-637 |
Verifying Explanatory Methods |
Thomas Lukasiewicz |
University of Oxford |
PLCO |
Jun 18, 2020 |
PLCO-638 |
Diet and lifestyle factors and lung cancer risk and mortality: Classification and regression tree analysis |
Qian Wang |
University Hospitals Seidman Cancer Center |
PLCO |
Jun 9, 2020 |
PLCO-633 |
Coffee consumption and risk of renal cell carcinoma in the PLCO cohort |
Jongeun Rhee |
NCI |
PLCO |
Jun 9, 2020 |
PLCO-632 |
Genome wide association study (GWAS) of cholangiocarcinoma (CCA) |
Katherine McGlynn |
National Cancer Institute |
PLCO |
Jun 2, 2020 |
PLCO-631 |
GSTM1-deletion in relation to cancer risk |
Ludmila Prokunina-Olsson |
NCI |
PLCO |
Jun 1, 2020 |
PLCO-629 |
Prostate BPC3 |
Neal Freedman |
NCI |
PLCO |
May 26, 2020 |
2004-9000 |
Interpretability of machine learning based prediction models for ovarian cancer classification using PLCO dataset |
Khyati Shah |
Liverpool John Moores University, UK |
PLCO |
May 20, 2020 |
PLCO-628 |
Additive proportional hazard model for interval-censored data |
Yan Liu |
University of Nevada, Reno |
PLCO |
May 12, 2020 |
PLCO-621 |
Exploring the latent space of integrated heterogeneous data sources in breast cancer |
David Longo |
Emergent Dynamics |
PLCO |
May 12, 2020 |
PLCO-623 |
Young adulthood adiposity, weight change, and other metabolic comorbidities with the risk of hepatobiliary cancer incidence and mortality in the PLCO study |
Xuehong Zhang |
The Brigham and Women's Hospital, Inc. |
PLCO |
Apr 30, 2020 |
PLCO-618 |
Studying the role of Clonal Hematopoiesis of Indeterminate Potential in disease progression from Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma |
Irene Ghobrial |
Dana-Farber Cancer Institute |
PLCO |
Apr 29, 2020 |
2019-1020 |
COVID: Using environmental data and modelling to test the hypothesis that spatial and seasonal patterns in vitamin D deficiency are associated with hospitalizations and mortality due to COVID-19 |
Elizabeth North |
University of Maryland Center for Environmental Science |
PLCO |
Apr 24, 2020 |
PLCO-617 |
The "MetaboMap" project |
Steven Moore |
NCI |
PLCO |
Apr 23, 2020 |
PLCO-615 |
Estimating the probability of overdiagnosis in PLCO trial |
Jian-Lun Xu |
NCI |
PLCO |
Mar 25, 2020 |
PLCO-600 |